Envision rejected KKR twice before accepting $9.9B offer — 4 insights

Nashville, Tenn.-based Envision Healthcare rejected two of KKR’s offers to acquire the company before accepting a $9.9 billion bid, the Nashville Business Journal reports.

Advertisement

Here’s what you should know:

1, Envision’s board rejected offers of $45.25 per share and $45.75 per share before agreeing to a $46 per share offer.

2. Envision shareholders approved the sale last week. It still must clear the Securities and Exchange Commission.

3. Once the sale closes, KKR will take Envision private.

4. Envision CEO Chris Holden will remain CEO after the sale. He said KKR won’t change how the company operates.

More articles on transactions/valuation:
Envision loses another contract over out-of-network billing & more — 11 ASC company key notes
Total charges for top 10 procedures performed at ASCs in the Northeast
10 strategies to streamline ASC supply chain management

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.